Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Medical innovation then and now: perspectives of innovators responsible for transformative drugs.

Xu S, Kesselheim AS.

J Law Med Ethics. 2014 Winter;42(4):564-75. doi: 10.1111/jlme.12176.

PMID:
25565621
2.

Clinicians' contributions to the development of coronary artery stents: a qualitative study of transformative device innovation.

Kesselheim AS, Xu S, Avorn J.

PLoS One. 2014 Feb 12;9(2):e88664. doi: 10.1371/journal.pone.0088664. eCollection 2014.

3.

Origins of medical innovation: the case of coronary artery stents.

Xu S, Avorn J, Kesselheim AS.

Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):743-9. doi: 10.1161/CIRCOUTCOMES.112.967398. Epub 2012 Oct 23. Review.

PMID:
23093563
4.

How does medical device regulation perform in the United States and the European union? A systematic review.

Kramer DB, Xu S, Kesselheim AS.

PLoS Med. 2012;9(7):e1001276. doi: 10.1371/journal.pmed.1001276. Epub 2012 Jul 31. Review.

5.

Regulation of medical devices in the United States and European Union.

Kramer DB, Xu S, Kesselheim AS.

N Engl J Med. 2012 Mar 1;366(9):848-55. doi: 10.1056/NEJMhle1113918. Epub 2012 Feb 14. No abstract available.

PMID:
22332952

Supplemental Content

Loading ...
Support Center